COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:

Isoeugenol (97-54-1)

DOI: https://doi.org/10.22427/NTP-DATA-DTXSID7022413


Study Results


Chronic Bioassay Level of Evidence

An overview of chronic evidence from Rats studies.
Rats
View
  • Equivocal Evidence, Male, Rats
  • No Evidence, Female, Rats
An overview of chronic evidence from Mice studies.
Mice
View
  • Clear Evidence, Male, Mice
  • Equivocal Evidence, Female, Mice

Genetic Toxicology

An overview of Genetic Toxicology Micronucleus Mice study conclusions related to Isoeugenol (97-54-1).
Micronucleus - Mice
View
  • Male: Negative
    Female: Positive
An overview of Genetic Toxicology Mammalian Cell Cytogenetics study conclusions related to Isoeugenol (97-54-1).
Mammalian Cell Cytogenetics
CA
An overview of Genetic Toxicology Bacterial Mutagenicity study conclusions related to Isoeugenol (97-54-1).
Bacterial Mutagenicity
View
  • Negative
View
  • Negative

Citation Information


NTP. Isoeugenol (97-54-1). Chemical Effects in Biological Systems (CEBS). Research Triangle Park, NC (USA): National Toxicology Program (NTP).

Publications


TR-551 NTP Toxicology and Carcinogenesis Studies of Isoeugenol (CASRN 97-54-1) in F344/N Rats and B6C3F1 Mice (Gavage studies)
Mortelmans, K., Haworth, S., Lawlor, T., Speck, W., Tainer, B., and Zeiger, E. Salmonella mutagenicity tests. II. Results from the testing of 270 chemicals Environ. Mutagen. Vol. 8 (Suppl 7) (1986) 1-119
Final Report on the Developmental Toxicity of Isoeugenol (CASRN 97-54-1) in Sprague-Dawley CD Rats Exposed on Gestation Days 6 - 19

Study Data


Toxicity and Carcinogenicity Studies


3-Month Evaluation of the Toxicity (C88105) of Isoeugenol (97-54-1) in F344 Rats Exposed via Gavage. NTP Special Study
3-Month Evaluation of the Toxicity (C88105) of Isoeugenol (97-54-1) in F344 Rats Exposed via Gavage. NTP Special Study
3-Month Evaluation of the Toxicity (C88105) of Isoeugenol (97-54-1) in B6C3F1 Mice Exposed via Gavage. NTP Special Study
3-Month Evaluation of the Toxicity (C88105) of Isoeugenol (97-54-1) in F344/N Rats Exposed via Gavage
3-Month Evaluation of the Toxicity (C88105) of Isoeugenol (97-54-1) in F344/N Rats Exposed via Gavage
3-Month Evaluation of the Toxicity (C88105) of Isoeugenol (97-54-1) in B6C3F1 Mice Exposed via Gavage
Evaluation of the Chronic Toxicity and Carcinogenicity (C88105) of Isoeugenol (97-54-1) in F344/N Rats Exposed via Gavage
Evaluation of the Chronic Toxicity and Carcinogenicity (C88105) of Isoeugenol (97-54-1) in B6C3F1 Mice Exposed via Gavage

Genetic Toxicology Studies


Genetic Toxicity Evaluation of Isoeugenol (97-54-1) in Micronucleus Study A67394 in B6C3F1 Mice
Genetic Toxicity Evaluation of Isoeugenol in Salmonella/E.coli Mutagenicity Test or Ames Test. Study 298252
Summary Data
Genetic Toxicity Evaluation of Isoeugenol in Salmonella/E.coli Mutagenicity Test or Ames Test. Study A66240
Summary Data

Other NTP Studies


Prenatal Developmental Toxicity Pilot Study (TRP97006) of Isoeugenol (97-54-1) in Sprague-Dawley Rats Exposed via Gavage
Prenatal Developmental Toxicity Study (TER97006) of Isoeugenol (97-54-1) in Sprague-Dawley Rats Exposed via Gavage
Toxicokinetic Evaluation (K10262) of Isoeugenol (97-54-1) in F344/N Rats and B6C3F1 Mice Exposed via Intravenous Injection or Gavage